Skip to main content
Published locations for Dupilumab offers long-term drug survival in moderate-to-severe atopic dermatitis in a real-world setting
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Dupilumab offers long-term drug survival in moderate-to-severe atopic dermatitis in a real-world setting
User login
Username
Password
Reset your password
/content/dupilumab-offers-long-term-drug-survival-moderate-severe-atopic-dermatitis-real-world
/dermatology/article/261370/atopic-dermatitis/dupilumab-offers-long-term-drug-survival-moderate